A

Arvinas

Clinical-stage biopharma developing PROTAC degraders

Medicinal Chemistry Project Leader

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • A PhD in organic chemistry or medicinal chemistry with at least 8 years of pharma or biotech-based drug discovery experience.
  • A proven track record of leading research projects through milestone decisions toward clinical candidate nomination.
  • Extensive experience in the synthetic and medicinal chemistry of antibody-drug conjugates.
  • Extensive knowledge of structure-based design, structure-activity relationship generation, and multi-parametric optimization.
  • Deep understanding of pharmacokinetic principles and in vivo pharmacology.
  • The ability to collaborate and communicate project needs and strategy to multidisciplinary team members and senior leaders.
  • Must be legally authorized to work in the United States without the need for employer sponsorship now or at any time in the future.
  • Must be able, with or without accommodation, to lift or carry 15 pounds unassisted and 30 pounds assisted; work comfortably in a controlled environment with and around biological, infectious, and hazardous materials; gown and degown personal protective equipment; use a computer; communicate via phone, video, and electronic messaging; engage in problem solving, analysis, and dialogue; collaborate with others; and maintain general availability during standard business hours.

Responsibilities

  • Drive milestone decision-making on assigned PROTAC projects, potentially focused on degrader-antibody conjugates, from inception to clinical candidate nomination in line with target product profiles and timelines within a team environment.
  • Expeditiously design PROTACs, degrader-antibody conjugates, and libraries in conjunction with state-of-the-art computational chemistry resources to advance programs.
  • Analyze complex, multivariate structure-activity relationship datasets to generate new testable hypotheses.
  • Interact dynamically with external contract research organization resources to ensure synthetic and data needs are fulfilled according to agreed timelines and standards.
  • Solicit and analyze necessary experimentation and data to identify and prioritize issues and support crisp decision-making within the project environment to meet company, project, and personal goals and timelines.
  • Drive smooth collaboration and decision-making with other functions in drug discovery through strong communication.
  • Exemplify leadership and demand excellence in performance at all levels.
  • Provide transparent, coherent, and focused scientific updates to the manager and company executives on request; represent company interests at conferences and in scientific matters to external organizations as needed.
  • Craft and communicate data-based strategic recommendations and decisions to research and development leadership.

Desired Qualifications

  • Specific experience with degrader-antibody conjugates is preferred.

About the Company

Arvinas

Clinical-stage biopharma developing PROTAC degraders

Arvinas develops therapies based on PROTAC protein degraders to target diseases driven by harmful proteins, including cancer and neurodegenerative disorders. PROTACs work by recruiting an E3 ligase to tag the disease-causing protein for degradation by the cell’s proteasome, removing the harmful protein rather than just blocking it. It differentiates itself with a proprietary PROTAC platform and by pursuing partnerships and licensing to fund multiple programs across oncology and neurodegeneration. The company aims to improve patient outcomes by delivering targeted, mechanism-based therapies and advancing drug candidates toward potential commercialization.

Company size
201-500
Company stage
IPO
Headquarters
New Haven, CT
Founded
2013

Recently Posted Jobs

Explore more opportunities at Arvinas

See more jobs